Weekly Recap | Zai Lab -2.8%, most brokers rate it buy
Weekly Review·
- Zai Lab shares fell 2.8% to close at 24.98 USD this week, underperforming the S&P 500 index by 4.01 percentage points amid shrinking trading volume and no major catalysts.
- Among 12 covering institutions, 9 rated the stock as a buy and 2 as overweight, resulting in a strong buy consensus with an average target price of 33.14 USD.
- Next week's focus will center on US macroeconomic data impacting the biotechnology sector's risk appetite, while Zai Lab has no major events or earnings reports scheduled.